S. Thiagalingam

S. Thiagalingam, M. Joghataei, H. Abdolmaleky, 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Genome‐wide association and multi‐omics studies identify MGMT as a novel risk gene for Alzheimer's disease among women

K. Lunetta, J. Haines, M. Pericak-Vance, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

PAK 1 , a gene that can regulate p 53 activity in yeast ( tumor suppressor / transactivation / posttranslational modification / phosphorylation )

K. Kinzler, B. Vogelstein, S. Thiagalingam, 2005 .

Nucleotide excision repair, a tracking mechanism in search of damage.

S. Thiagalingam, L. Grossman, Lawrence Grossman, 1993, The Journal of biological chemistry.

NADH dehydrogenase and NADH oxidation inBacillus megaterium

S. Thiagalingam, Tsanyen Yang, 1986, Current Microbiology.

Genetics and Epigenetics in Major Psychiatric Disorders

M. Wilcox, S. Thiagalingam, H. Abdolmaleky, 2005, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

Activins, Inhibins, and Bone Morphogenetic Proteins as Modulators and Biomarkers of Prostate Cancer Progression

S. Maheswaran, S. Thiagalingam, Vandana Gupta, 2008 .

Epigenetic memory in development and disease: Unraveling the mechanism.

S. Thiagalingam, 2020, Biochimica et biophysica acta. Reviews on cancer.

DNA hypermethylation of serotonin transporter gene promoter in drug naïve patients with schizophrenia

S. Thiagalingam, Mohammad Ghadirivasfi, H. Abdolmaleky, 2014, Schizophrenia Research.

Systems Biology of Cancer: Systems biology of cancer progression

S. Thiagalingam, 2015 .

Smad4 inactivation promotes malignancy and drug resistance of colon cancer.

Jin-Rong Zhou, S. Thiagalingam, P. Papageorgis, 2011, Cancer research.

Therapeutics , Targets , and Chemical Biology Smad 4 Inactivation Promotes Malignancy and Drug Resistance of Colon Cancer

S. Thiagalingam, P. Papageorgis, H. Abdolmaleky, 2011 .

Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence

S. Thiagalingam, A. Thiagalingam, Sam Thiagalingam, 2002, Current opinion in oncology.

Mechanisms underlying losses of heterozygosity in human colorectal cancers

K. Kinzler, B. Vogelstein, J. Willson, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Molecular detection of smad2/smad4 alterations in colorectal tumors.

S. Thiagalingam, 2001, Methods in molecular medicine.

Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code

Kuang-Hung Cheng, S. Thiagalingam, A. Thiagalingam, 2003, Annals of the New York Academy of Sciences.

Homeosis and polyposis: a tale from the mouse.

T. He, L. D. da Costa, S. Thiagalingam, 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis

A. Tzatsos, S. Thiagalingam, P. Papageorgis, 2015, Breast Cancer Research.

Smad signaling is required to maintain epigenetic silencing during breast cancer progression.

M. Lenburg, S. Thiagalingam, U. Manne, 2010, Cancer research.

Aberrant activation of γ-catenin promotes genomic instability and oncogenic effects during tumor progression

D. Faller, S. Thiagalingam, P. Papageorgis, 2007, Cancer biology & therapy.

DNA Methylation Profiles as Prognostic Markers for Cancer

S. Thiagalingam, P. Papageorgis, 2008 .

Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.

J. Califano, D. Sidransky, S. Thiagalingam, 2005, Cancer research.

Reduced Risk of Cancer in Schizophrenia, a Bridge Toward Etio-Pathology and Therapy of Both Diseases

Mehrad Amin Eskandari, S. Thiagalingam, H. Abdolmaleky, 2015 .

Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: A preliminary report

S. Faraone, M. Tsuang, S. Glatt, 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.

B. Vogelstein, J. Massagué, J. Lutterbaugh, 2001, Cancer research.

Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.

K. Kinzler, B. Vogelstein, L. Myeroff, 1999, Cancer research.

Frequency of Smad gene mutations in human cancers.

K. Kinzler, B. Vogelstein, G. Riggins, 1997, Cancer research.

Oncogenic forms of p53 inhibit p53-regulated gene expression.

K. Kinzler, B. Vogelstein, S. Kern, 1992, Science.

Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder.

S. Faraone, M. Tsuang, S. Glatt, 2006, Human molecular genetics.

p53 tagged sites from human genomic DNA.

K. Kinzler, B. Vogelstein, T. Tokino, 1994, Human molecular genetics.

Evaluation of the FHIT gene in colorectal cancers.

M. Wigler, K. Kinzler, B. Vogelstein, 1996, Cancer research.

Oncogenic forms of p53 inhibit p53-regulated gene expression

K. Kinzler, B. Vogelstein, S. Kern, 1992 .

The Cancer Epigenome

D. Faller, S. Thiagalingam, 2008 .

Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis

A. Tzatsos, S. Thiagalingam, P. Papageorgis, 2015, Breast Cancer Research.

TumorCell-DerivedPeriostinRegulatesCytokines That Maintain Breast Cancer Stem Cells

S. Thiagalingam, P. Papageorgis, M. Reinhard, 2016 .

Tumor Cell-Derived Periostin Regulates Cytokines That Maintain Breast Cancer Stem Cells

S. Thiagalingam, P. Papageorgis, H. Abdolmaleky, 2015, Molecular Cancer Research.

Epigenetic and pharmacoepigenomic studies of major psychoses and potentials for therapeutics.

S. Thiagalingam, H. Abdolmaleky, Jin-Rong Zhou, 2008, Pharmacogenomics.

Epigenetic Modulation of Reelin Function in Schizophrenia and Bipolar Disorder

S. Thiagalingam, H. Abdolmaleky, Jin-Rong Zhou, 2008 .

hBub1 deficiency triggers a novel p53 mediated early apoptotic checkpoint pathway in mitotic spindle damaged cells

S. Thiagalingam, P. Papageorgis, A. Thiagalingam, 2009, Cancer biology & therapy.

Elucidation of Epigenetic Inactivation of SMAD8 in Cancer Using Targeted Expressed Gene Display

S. Thiagalingam, Kuang-Hung Cheng, Jose F. Ponte, 2004, Cancer Research.

Purification and characterization of NADH dehydrogenase from Bacillus megaterium

S. Thiagalingam, Tsanyen Yang, 1993 .

An update on the epigenetics of psychotic diseases and autism.

S. Thiagalingam, H. Abdolmaleky, Jin-Rong Zhou, 2015, Epigenomics.

DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder.

S. Thiagalingam, Mohammad Ghadirivasfi, H. Abdolmaleky, 2011, Journal of psychiatric research.

Hypomethylation of the serotonin receptor type‐2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder

S. Thiagalingam, Mohammad Ghadirivasfi, H. Abdolmaleky, 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Epigenetic alterations of the dopaminergic system in major psychiatric disorders.

S. Thiagalingam, H. Abdolmaleky, Jin-Rong Zhou, 2008, Methods in molecular biology.

Aberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality/asymmetry in schizophrenia and bipolar disorder

S. Thiagalingam, A. Thiagalingam, H. Abdolmaleky, 2018, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis

S. Thiagalingam, P. Papageorgis, A. Thiagalingam, 2016, Proceedings of the National Academy of Sciences.

Integrin Signaling in Mammary Epithelial Cells and Breast Cancer

S. Thiagalingam, Arthur W. Lambert, Sam Thiagalingam, 2012, ISRN oncology.

Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan

B. Győrffy, S. Thiagalingam, P. Papageorgis, 2020, Molecular Cancer Research.

Methamphetamine‐induced psychosis is associated with DNA hypomethylation and increased expression of AKT1 and key dopaminergic genes

S. Thiagalingam, M. Joghataei, Mohammad Ghadirivasfi, 2016, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Epigenetic Alterations of Brain Non-Neuronal Cells in Major Mental Diseases

S. Thiagalingam, H. Abdolmaleky, Jin-Rong Zhou, 2023, Genes.

MicroRNA-4417 is a tumor suppressor and prognostic biomarker for triple-negative breast cancer

S. Thiagalingam, P. Papageorgis, A. Thiagalingam, 2019, Cancer biology & therapy.

Genome‐wide association and multi‐omics studies identify MGMT as a novel risk gene for Alzheimer disease among women

K. Lunetta, J. Haines, M. Pericak-Vance, 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

S1P1 Threonine 236 Phosphorylation Mediates the Invasiveness of Triple-Negative Breast Cancer and Sensitivity to FTY720

Ching‐Ti Liu, S. Thiagalingam, J. Berman, 2023, Cells.

Psychiatric Epigenetics: A Key to the Molecular Basis of and Therapy for Psychiatric Disorders

M. Tsuang, S. Thiagalingam, H. Abdolmaleky, 2013 .

Can the schizophrenia epigenome provide clues for the molecular basis of pathogenesis?

S. Thiagalingam, H. Abdolmaleky, 2011, Epigenomics.